Achilles Therapeutics plc (ACHL) Social Stream



Achilles Therapeutics plc (ACHL): $2.41

0.07 (+2.99%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Achilles Therapeutics plc (ACHL) Price Targets From Analysts

Use the tables below to see what analysts covering Achilles Therapeutics plc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-12 5 $27 $6 $19 $2.98 537.58%
2022-03-02 5 $27 $7 $19.2 $2.98 544.3%
2022-03-03 5 $27 $7 $17.8 $2.98 497.32%
2022-03-31 5 $27 $7 $17.4 $2.98 483.89%

ACHL reports an average of 355.8% for its upside potential over the past 177 days.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-10-05 5 27 6 19.0 7.55 151.66%
2021-11-12 5 27 7 19.2 6.18 210.68%
2022-03-02 5 27 7 19.2 3.23 494.43%
2022-03-03 5 27 7 17.8 3.10 474.19%
2022-03-31 5 27 7 17.4 2.94 491.84%

ACHL Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.8 4 0 0 1 1 5

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In the context of all US stocks, Achilles Therapeutics plc's upside potential (average analyst target price relative to current price) is higher than 385.94% of them.
  • ACHL has a lower variance in analysts' estimates than -276.22% of all US stocks.
  • To contextualize these metrics, consider that out of Healthcare stocks, Achilles Therapeutics plc's average analyst price target is higher than 121.57% of them.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, Achilles Therapeutics plc's number of analysts covering the stock is higher than 255.44% of them.

Stocks similar to Achilles Therapeutics plc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ABOS, MTEX, and MNMD.

Make investment decisions regarding ACHL using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6408 seconds.